(S (NP (NP (DT A) (JJ key) (NN goal)) (PP (IN of) (NP (JJ computational) (JJ personalized) (NN medicine)))) (VP (VBZ is) (S (VP (TO to) (VP (ADVP (RB systematically)) (VB utilize) (NP (NP (ADJP (ADJP (JJ genomic)) (CC and) (ADJP (JJ other) (JJ molecular))) (NNS features)) (PP (IN of) (NP (NNS samples)))) (S (VP (TO to) (VP (VB predict) (NP (NP (NN drug) (NNS responses)) (PP (IN for) (NP (DT a) (ADJP (RB previously) (JJ unseen)) (NN sample))))))))))) (. .))
(S (NP (JJ Such) (NNS predictions)) (VP (VBP are) (ADJP (JJ valuable) (PP (IN for) (S (VP (VBG developing) (NP (NP (NNS hypotheses)) (PP (IN for) (S (VP (VBG selecting) (NP (NP (NNS therapies)) (VP (VBN tailored) (PP (IN for) (NP (JJ individual) (NNS patients)))))))))))))) (. .))
(S (NP (DT This)) (VP (VBZ is) (ADJP (RB especially) (JJ valuable)) (PP (IN in) (NP (NP (NN oncology)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NP (ADJP (JJ molecular) (CC and) (JJ genetic)) (NN heterogeneity)) (PP (IN of) (NP (DT the) (NNS cells)))) (VP (VBZ has) (NP (NP (DT a) (JJ major) (NN impact)) (PP (IN on) (NP (DT the) (NN response)))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (DT the) (NN prediction) (NN task)) (VP (VBZ is) (ADJP (RB extremely) (JJ challenging)) (, ,) (S (VP (VBG raising) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NP (NNS methods)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (ADVP (RB effectively)) (VB model) (CC and) (JJ predict) (NP (NN drug) (NNS responses)))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ novel) (NN formulation)) (PP (IN of) (NP (JJ multi-task) (NN matrix) (NN factorization))) (SBAR (WHNP (WDT that)) (S (VP (VBZ allows) (NP (JJ selective) (NNS data) (NN integration)) (PP (IN for) (S (VP (VBG predicting) (NP (NN drug) (NNS responses)))))))))) (. .))
(S (S (VP (TO To) (VP (VB solve) (NP (DT the) (NN modeling) (NN task))))) (, ,) (NP (PRP we)) (VP (VBP extend) (NP (DT the) (JJ state-of-the-art) (JJ kernelized) (JJ Bayesian) (NN matrix) (NN factorization) (PRN (-LRB- -LRB-) (NNP KBMF) (-RRB- -RRB-)) (NN method)) (PP (IN with) (NP (JJ component-wise) (JJ multiple) (NN kernel) (NN learning)))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP$ our) (NN approach)) (VP (VBZ exploits) (NP (DT the) (JJ known) (NN pathway) (NN information)) (PP (IN in) (NP (DT a) (ADJP (ADJP (NN novel)) (CC and) (ADJP (RB biologically) (JJ meaningful))) (NN fashion))) (S (VP (TO to) (VP (VB learn) (NP (DT the) (NN drug) (NN response) (NNS associations)))))) (. .))
(S (NP (PRP$ Our) (NN method)) (VP (ADVP (RB quantitatively)) (VBZ outperforms) (NP (NP (DT the) (NN state)) (PP (IN of) (NP (DT the) (NN art)))) (PP (PP (IN on) (S (VP (VBG predicting) (NP (NN drug) (NNS responses)) (PP (IN in) (NP (CD two) (ADJP (RB publicly) (JJ available)) (NN cancer) (NNS data) (NNS sets)))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN on) (NP (DT a) (JJ synthetic) (NN data) (NN set))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBD validated) (NP (PRP$ our) (NN model) (NNS predictions)) (PP (IN with) (NP (NP (NN lab) (NNS experiments)) (VP (VBG using) (NP (DT an) (JJ in-house) (NN cancer) (NN cell) (NN line) (NN panel)))))) (. .))
(S (NP (PRP We)) (ADVP (RB finally)) (VP (VBP show) (NP (NP (DT the) (JJ practical) (NN applicability)) (PP (IN of) (NP (DT the) (VBN proposed) (NN method)))) (PP (IN by) (S (VP (VBG utilizing) (NP (RB prior) (NN knowledge)) (S (VP (TO to) (VP (VB infer) (NP (JJ pathway-drug) (NN response) (NNS associations))))) (, ,) (S (VP (VBG opening) (PRT (RP up)) (NP (NP (DT the) (NN opportunity)) (PP (IN for) (S (VP (VBG elucidating) (NP (NN drug) (NN action) (NNS mechanisms)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (JJ pathway-response) (NNS associations)) (VP (MD can) (VP (VB be) (VP (VBN learned) (PP (IN by) (NP (NP (DT the) (VBN proposed) (NN model)) (PP (IN for) (NP (DT the) (ADJP (NN well) (VBN known)) (NNP EGFR) (CC and) (NNP MEK) (NNS inhibitors))))))))))) (. .))
